Scinovex
article Open Access

Leprosy and the scenery of COVID-19

International Journal of Dermatology Sciences · 2021 · Vol. 3(1) · pp. 06–07

Abstract

The potentially negative consequences of COVID-19 in the routine assistance of leprosy patients should merit special attention of the health and political authorities in underdeveloped regions with a higher prevalence of the ancient mycobacterial infection. Effective strategies are needed to protect patients and maintain the control of leprosy, while the preventive health public measures against COVID-19 are strictly followed. Pathophysiological mechanisms can be shared by leprosy and SARS-Cov 2 infection. Actually, either old or new infectious diseases should deserve enough attention by health workers, mainly whether the same population group is more prone to be affected.

Leprosy Research and TreatmentTuberculosis Research and EpidemiologyInfectious Diseases and TuberculosisLeprosyPublic healthCoronavirus disease 2019 (COVID-19)MedicinePopulation2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Environmental healthImmunologyDisease
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
23%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.